Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

7.18
+0.29504.29%
Volume:260.34K
Turnover:1.86M
Market Cap:322.86M
PE:-3.31
High:7.35
Open:6.95
Low:6.91
Close:6.88
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:1.15
T/O Rate:1.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:1.21
PE(LYR):-3.81

Loading ...

Sionna Therapeutics joins RBC Capital Markets Global Healthcare Conference fireside chat

Reuters
·
May 13

Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG

Dow Jones
·
May 13

Sionna Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Sector Update: Healthcare

MT Newswires Live
·
May 12

Sionna Therapeutics reports Q1 EPS (60c), consensus (50c)

TIPRANKS
·
May 12

Earnings Flash (SION) Sionna Therapeutics Posts Q1 Net Loss $0.60 a Share, vs. FactSet Est of $0.54 Loss

MT Newswires Live
·
May 12

Sionna Therapeutics Q1 EPS $(0.60) Misses $(0.51) Estimate

Benzinga Earnings
·
May 12

Sionna Therapeutics Q1 net loss widens, misses estimates

Reuters
·
May 12

Sionna Therapeutics Inc - Maintains Cash Position of $289.9 Mln; Expects to Fund Operations Into 2028

THOMSON REUTERS
·
May 12

Sionna Therapeutics Inc Q1 Income From Operations USD -29.599 Million

THOMSON REUTERS
·
May 12

Sionna Therapeutics Inc Q1 Basic EPS USD -0.6

THOMSON REUTERS
·
May 12

Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results

Dow Jones
·
May 12

Sionna Therapeutics director Peter A. Thompson sells 292,952 shares for $13.37 million

Reuters
·
May 12

OrbiMed Advisors disposes 292,952 Sionna Therapeutics shares for $13.5 million

Reuters
·
May 12

Sionna Therapeutics Initiated at Outperform by Wedbush

Dow Jones
·
May 05

Sionna Therapeutics Inc : Wedbush Initiates Coverage With Outperform Rating; Target Price $53

THOMSON REUTERS
·
May 05

Wedbush Initiates Sionna Therapeutics at Outperform With $53 Price Target

MT Newswires Live
·
May 05

Is Sionna Therapeutics (SION) Stock Overvalued After Its Strong 1 Year Run And 6x P/B Multiple

Simply Wall St.
·
May 05

Sionna Therapeutics initiated with an Outperform at Wedbush

TIPRANKS
·
May 05

Sionna Therapeutics Is Maintained at Buy by Jones Trading

Dow Jones
·
Apr 29